The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023
Sense anticipates launching Veros Covid-19 in Europe this quarter, initially in Ireland, Benelux and the Nordic regions
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care
New inhalers would have near-zero Global Warming Potential propellant
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
Darolutamide is developed jointly by Bayer and Orion Corporation
Subscribe To Our Newsletter & Stay Updated
